Investigating the role of the BAF Complex in Human Disease and Evolution Öffentlichkeit

Davis, Sona (Spring 2024)

Permanent URL: https://etd.library.emory.edu/concern/etds/q237ht583?locale=de
Published

Abstract

This Honors Thesis contains two projects each addressing gaps in our current knowledge on the BAF complex. The first project (described in Chapter 2) sought to identify areas of the genome where the BAF Complex works to remodel chromatin. The second project (described in Chapter 3) sought to determine whether there are genetic variations in BAF subunit genes between modern humans, ancient humans, and non-human primates that could contribute to differences in brain development in these populations. Together, these projects deepen our understanding of the role of the BAF Complex in human evolution and disease. The results provide strong baselines for future research on BAF function, as well as intriguing insights into its implications. Moreover, they pave the way for potential therapeutic interventions and open up new avenues for exploring the intricate interplay between the BAF Complex and various biological processes.

Table of Contents

Overview of Project 1

Overview of Project 2

1.1: DNA Structure and Packaging

1.2: Chromatin-Based Regulation of Gene Expression

1.3: BRG1/BRM Associated Factor Family of Chromatin Remodeling

1.4: BAF Mutations in Human Disease

2.1: Background

2.1.2: BAF complexes are bound at cREs and required to maintain chromatin accessibility.

2.1.3: Key gap(s) in knowledge

2.1.4: Our approach

2.2: Results

2.2.1: Primer pairs and qualitative PCR assay successfully measure signal to noise ratio of ATAC-Seq Libraries.

2.2.2: ATAC-seq Libraries from K-562 cell-line have high signal to noise ratio.

2.2.3: Identifying optimal concentration to treat K-562 with BAF inhibiting drug.

2.2.5: Surprisingly, BAF Inhibition does not lead to loss of chromatin accessibility.

2.3: Methods

2.3.1: Primer Design

2.3.2: pCR

2.3.3: Gel Electrophoresis

2.3.4: qPCR

2.3.5: Drug Inhibitor Dose Escalation

2.3.6: Cell Culture and Treatment

2.3.7: ATAC-Seq

2.3.8: Next-Generation Sequencing and Analysis

2.4: Conclusions

2.4.1: The inhibition of the BAF complex in the K-562 cell line does not result in significant changes in accessibility.

2.4.2: Limitations

2.4.3: Potential Next Steps

3.1: Background

3.1.1: The BAF Complex in Brain Development

3.1.2: The Evolutionary Conservation of the BAF Complex

3.1.3: Single Nucleotide Polymorphisms and Missense Mutations

3.1.4: Non-Human Primates

3.1.5: Neanderthals

3.2: Results

3.2.1: Identifying variants in BAF Protein subunits’ genes.

3.2.2: Predicting the impact of genetic variants on BAF protein structure and function.

3.2.3: Identifying variants predicted to be “Damaging”by all three computational tools.

3.3.7: Determining variants’ presence in the human population.

3.3: Methods

3.3.1: Obtaining variants between the human genome and Neanderthal/Non-Human Primate Genomes

3.3.2: Filtering for Coding Sequences within Exons

3.3.3: Bedtools Intersect

3.3.4: CADD

3.3.5: SIFT

3.3.6: PolyPhen-2

3.4: Conclusions

3.4.1: Eight individuals of the non-human primates analyzed in my study have a genetic variant in SMARCE1 that is predicted to cause NDD in humans.

3.4.2: Limitations

3.4.3: Potential Next Steps

Works Cited

About this Honors Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Degree
Submission
Language
  • English
Research Field
Stichwort
Committee Chair / Thesis Advisor
Committee Members
Zuletzt geändert

Primary PDF

Supplemental Files